Novavax COVID-19 Vaccine Proves to be Highly Effective in Late-Stage Trial
Novavax COVID-19 Vaccine Proves to be Highly Effective in Late-Stage Trial

The American biotechnology company Novavax is set to offer the US a fourth COVID-19 vaccine.

Veuer’s Maria Mercedes Galuppo has the story.